Top Image
Advanced Centre for Treatment Research & Education in Cancer
Facebook Twitter Gmail
Banner Image
Science Sparks @ ACTREC
Date Image 13th June 2022 Vol. No. 11; Issue No. 530

1. Raj M, Shinde A, Ingle A (2022). Microbiological monitoring of Rodent pathogens using Multiplex method of PCR. Journal of Laboratory Animal Science.7 (1): 18-24.

2. Thorat R, Ahire S, Shinde A, Ingle A (2022). Cost-effective decontamination of conventional laboratory animal rooms using hydrogen peroxide aerosols. Journal of Laboratory Animal Science. 7(1): 32-36.

3. Tambe M, Pinto A, D'Silva SZ, Singh M (2022). Identification of the novel HLA allele, HLA-DRB1*14:50:02, in an individual from southern India. HLA.

4. Verghote F, Sargos P, Christodouleas JP, Murthy V, Baumann B, Dirix P, Berghen C, Paelinck L, Vercauteren T, Fonteyne V (2022). International consensus guidelines for adjuvant radiation therapy for bladder cancer after radical cystectomy: Update from an IBIS workgroup. Practical Radiation Oncology.

5. Jobanputra K, Nayak L, Jain H, Shet T, Epari S, Bonda VN, Thorat J, Bagal B, Laskar S, Rangarajan V, Agrawal A, Gujral S, Khanna N, Goda J, Sengar M (2022). Diffuse large B-Cell lymphoma in the elderly: Real-world outcomes from a developing ountry. Clinical Lymphoma Myeloma and Leukemia.

6. Sunkara RR, Mehta D, Sarate RM, Waghmare SK (2022). BMP-AKT-GSK3β signalling restores hair follicle stem cells decrease associated with loss of Sfrp1. Stem Cells.

Rahul Mahendra Mojidra. 2022. Genomic profiling of blast cells from different clinical stages of CML.( LIFE 09201404014) (Guide: Dr. Rukmini Govekar)

Site of the Week

HAGR Genetic database platform designed to help researchers study the genetics of human and animal aging.

desktop Image
Interesting Reads

De Silva K, Demmer RT, Jönsson D, Mousa A, Teede H, Forbes A, Enticott J. Causality of anthropometric markers associated with polycystic ovarian syndrome: Findings of a Mendelian randomization study. PLoS ONE 17(6): e0269191, 2022.

Legends of Science
Amitabha Mukhopadhyay Amitabha Mukhopadhyay

Amitabha Mukhopadhyay obtained his Ph.D. from the Institute of Microbial Technology, Chandigarh, in 1983. His primary research areas are cell biology, with particular emphasis on the regulation of intracellular trafficking. His other contribution is to demonstrate the feasibility of exploiting the receptor-mediated endocytic pathway to deliver a drug, specifically to macrophages, for various therapeutic purposes with reduced drug toxicity. Dr. Mukhopadhyay is a fellow of the National Academy of Sciences, Allahabad. He was a recipient of the National Bioscience Award in 2001 and; the SS Bhatnagar award in 2002.

Vishwas Anant Bapat Vishwas Anant Bapat

Vishwas Anant Bapat received his Ph.D. from the University of Mysore in 1981. His significant work was on tissue culture of sandalwood and mulberry; Banana micropropagation technology. He established plant protoplast culture and regeneration systems and worked on in vitro mutagenesis using radiation in bananas and sugarcane to induce novel genetic variability. His other research includes rescue of endangered plants, phytoremediation of industrial waste materials, analysis of uncommon fruits/ vegetables for nutritional components, and synthesis of nanoparticles using plant cells. He is an elected fellow of the National Academy of Sciences, Allahabad.

Upcoming Events
UICC’s 2022 World Cancer Congress

18-20 October, 2022

At Geneva, Switzerland

4th Indo Oncology Summit 2022

11-13 November, 2022

At Bhubaneswar, India

7th World Cancer Congress - 2022

19-20 November, 2022

At Banglore, India

Do You Know?

In 1990, Tasuku Honjo and colleagues demonstrated that PD-1 knockout mice develop autoimmune syndromes, suggesting that the receptor PD-1 is an immune checkpoint.

back Image
Cancer News
Drug cures 100 per cent of colorectal cancer patients in small initial trial.

08 June 2022, Science Focus

A team of researchers at the Memorial Sloan Kettering Cancer Center in New York used a PD-1 blocking drug called dostarlimab to treat 14 patients with MMrD stage two or stage three rectal cancers...

Scientists discover new molecule that kills hard to treat cancers

09 June 2022, EurekAlert

A new molecule synthesized by a University of Texas at Dallas researcher kills a broad spectrum of hard-to-treat cancers, including triple-negative breast cancer, by exploiting a weakness in cells not previously targeted by other drugs...

Recurring brain tumors shaped by genetic evolution and microenvironment

09 June 2022, MedicalXpress

Researchers have discovered that infiltrating gliomas, a common brain and spinal cord tumor, are shaped by their genetic evolution and microenvironment, a finding that could lead to more targeted treatments...

� 2022 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)